DOC 330.09(3)(a)3. 3. That the offender has a diagnosis for pedophilia or any other diagnosis for which an antiandrogen may be prescribed.
DOC 330.09(3)(b) (b) Once the department has established all of the criteria in sub. (3) (a), pharmacological treatment shall be ordered unless the serious child sex offender can establish by a preponderance of the evidence all of the following:
DOC 330.09(3)(b)1. 1. Pharmacological treatment of the offender is not necessary for public protection.
DOC 330.09(3)(b)2. 2. Pharmacological treatment will not further the rehabilitation of the serious child sex offender.
DOC 330.09 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.10 DOC 330.10Qualification of hearing examiner. The hearing examiner may not be currently involved in the offender's treatment, diagnosis, or supervision, or in the direct supervision of the agent or physician treating the offender.
DOC 330.10 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.11 DOC 330.11Offender advocate. An advocate of the offender's choosing may represent a serious child sex offender. The advocate may present witnesses and evidence on behalf of the serious child sex offender and cross-examine department witnesses. The advocate may not be a person in the custody or under the supervision of the department.
DOC 330.11 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.12 DOC 330.12Appeal of decision. The serious child sex offender or the department may appeal a decision of the hearing examiner to the division administrator within 10 days of the written decision.
DOC 330.12 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.13 DOC 330.13Review of decision.
DOC 330.13(1) (1) Every 24 months, a hearing examiner shall review the decision ordering mandatory compliance with required pharmacological treatment in accordance with the standards in s. DOC 330.09 (3).
DOC 330.13(2) (2) A different hearing examiner may perform the review.
DOC 330.13(3) (3) Upon request of the serious child sex offender the review shall be in the form of a pharmacological treatment hearing.
DOC 330.13(4) (4) The hearing examiner may continue the order permitting the department to require prescribed pharmacological treatment if evidence since the time of the last review shows that all of the criteria in s. DOC 330.09 (3) (a) have been satisfied.
DOC 330.13(5) (5) When the department has established all of the criteria in s. DOC 330.09 (3) (a), pharmacological treatment shall be continued unless the offender can establish all of the criteria in s. DOC 330.09 (3) (b).
DOC 330.13 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.14 DOC 330.14Waiver. A serious child sex offender may sign a form waiving the pharmacological treatment hearing or review.
DOC 330.14 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.15 DOC 330.15Detention pending clinical and medical evaluation or pharmacological treatment hearing.
DOC 330.15(1)(1) An offender who prior to parole refuses to participate in pharmacological treatment evaluations or the hearing process or refuses to take pharmacological treatment medications may be taken into custody and detained in any state correctional institution or county jail for the purpose of public protection.
DOC 330.15(2) (2) Detention under sub. (1) may continue until the pharmacological treatment evaluations are completed, the hearing decision is received, and the therapeutic level of the serious child sex offender is achieved.
DOC 330.15 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.16 DOC 330.16Duration of treatment. Pharmacological treatment shall be continued throughout the duration of the serious child sex offender's supervision unless one of the following applies:
DOC 330.16(1) (1) The serious child sex offender is found not to be a proper medical subject.
DOC 330.16(2) (2) The pharmacological treatment hearing process described in s. DOC 330.09 results in a finding that the department may not order pharmacological treatment for the serious child sex offender.
DOC 330.16(3) (3) The department determines that continuing pharmacological treatment will no longer be beneficial.
DOC 330.16 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
DOC 330.17 DOC 330.17Rules and conditions established; the serious child sex offender's duty to comply; department's response upon serious child sex offender's refusal to comply.
DOC 330.17(1)(1) The department shall establish special written rules and conditions of supervision for each serious child sex offender ordered to comply with pharmacological treatment as provided in s. DOC 328.04 (2) (d). The rules and conditions of supervision and any sanctions the department may use in response to non-compliance by the serious child sex offender shall be explained to the offender and acknowledged in writing.
DOC 330.17(2) (2) Serious child sex offenders required to undergo pharmacological treatment shall comply with all rules and conditions ordered by the parole commission or the department.
DOC 330.17(3) (3) Serious child sex offenders refusing to comply with rules and conditions of pharmacological treatment after a decision by a hearing examiner permitting the department to require pharmacological treatment may be sanctioned or recommended for revocation.
DOC 330.17 History History: Cr. Register July, 1999, No. 523, eff. 8-1-99.
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.